Ann: US$65m for 5% sale of Goulamina and Continued Suspension, page-400

I've tried to not pay too much attention to this while I can't do anything.

But having a look now and sentiment seems to have turned pretty bleak over the past few months.

What have I missed? Is there a chance we get delisted and see nothing of what we have tied up?

Pros:

• Gangfeng - I was pretty peeved when we gave away so much, so cheap to these guys. But having their Chinese dickswinging power may save us here.
• 80% complete - If Simon thought we wouldn't be okay, he should immediately halt progress in the interest of shareholders. He hasn't done this.